drug · antibody drug conjugate
patient view →ifinatamab deruxtecan
pre_registrationupdated 2mo agoby Daiichi Sankyo Co Ltd🔗 ChEMBL
community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Phase 3 (across all indications), with 2 investigational indications.
indications
indications
NSCLCBreast CancerMelanoma
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that